MENU
+Compare
SNTI
Stock ticker: NASDAQ
AS OF
Oct 8, 04:57 PM (EDT)
Price
$1.78
Change
+$0.05 (+2.89%)
Capitalization
45.26M

SNTI Senti Biosciences Inc. Forecast, Technical & Fundamental Analysis

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases... Show more

SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SNTI with price predictions
Oct 07, 2025

SNTI in +8.12% Uptrend, rising for three consecutive days on October 07, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where SNTI advanced for three days, in of 193 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 22, 2025. You may want to consider a long position or call options on SNTI as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SNTI just turned positive on September 11, 2025. Looking at past instances where SNTI's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

SNTI moved above its 50-day moving average on October 03, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SNTI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SNTI broke above its upper Bollinger Band on October 01, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SNTI entered a downward trend on September 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.836) is normal, around the industry mean (23.421). P/E Ratio (4.270) is within average values for comparable stocks, (54.441). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.237). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (38.023) is also within normal values, averaging (342.085).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. SNTI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SNTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
2 Corporate Drive
Phone
+1 650 239-2030
Employees
48
Web
https://www.sentibio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GALT4.770.33
+7.43%
Galectin Therapeutics
PM154.551.01
+0.66%
Philip Morris International
USEG1.22N/A
N/A
US Energy Corp
ELP9.26-0.25
-2.63%
Companhia Paranaense de Energia - COPEL
LB54.41-2.67
-4.68%
LandBridge Company LLC

SNTI and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SNTI has been loosely correlated with PPBT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if SNTI jumps, then PPBT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNTI
1D Price
Change %
SNTI100%
+3.59%
PPBT - SNTI
60%
Loosely correlated
-4.69%
TCRT - SNTI
47%
Loosely correlated
+18.11%
INBX - SNTI
41%
Loosely correlated
-4.18%
PTCT - SNTI
32%
Poorly correlated
-1.38%
DARE - SNTI
32%
Poorly correlated
-0.22%
More